Detalhe da pesquisa
1.
IFNL3 polymorphisms and HCV infection in patients with beta thalassemia.
Ann Hepatol
; 14(3): 389-95, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25864220
2.
Natural history of hepatitis C in thalassemia major: a long-term prospective study.
Eur J Haematol
; 90(6): 501-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23414443
3.
Renal function in patients with ß-thalassaemia major: a long-term follow-up study.
Nephrol Dial Transplant
; 27(9): 3547-51, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22695832
4.
Thalassemia intermedia is associated with a proatherogenic biochemical phenotype.
Blood Cells Mol Dis
; 46(4): 294-9, 2011 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21402483
5.
Evidence for a proatherogenic biochemical phenotype in beta thalassemia minor and intermedia.
Acta Haematol
; 126(2): 87-94, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21576933
6.
Case report: thalassemia intermedia patient with hypertension non-responsive to combined medical treatment.
Pediatr Endocrinol Rev
; 8 Suppl 2: 337-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21705990
7.
Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone.
Blood Cells Mol Dis
; 45(2): 136-9, 2010 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20678715
8.
Human immunodeficiency virus and beta-thalassemia major: A "competition of guilt" for pulmonary arterial hypertension. Report of a case and a review of the literature.
Hemoglobin
; 34(1): 61-6, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20113290
9.
Anemia in beta-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression.
Haematologica
; 93(1): 111-5, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18166793